Cefuroxime + Clavulanic Acid in pharma in Chhattisgarh

Cefuroxime + Clavulanic Acid in PCD pharma franchise in Chennai

Cefuroxime + Clavulanic Acid in top pharma company in Belagavi

Cefuroxime + Clavulanic Acid in pcd pharma supplier in Amritsar

Cefuroxime + Clavulanic Acid in phama franchise company in India
Cefuroxime + Clavulanic Acid in phama distributor in Jamshedpur

Home/Products /cefuroxime-500mg-clavulanic-acid-125mg-tablet

About the Product

Description


Cefuzrom CV Tablet combines two potent antibiotics, cefuroxime and clavulanic acid, to provide a broad-spectrum antibacterial effect. Cefuroxime is a cephalosporin antibiotic effective against a wide range of gram-positive and gram-negative bacteria, making it a valuable treatment for various infections. Clavulanic acid, a beta-lactamase inhibitor, enhances the efficacy of cefuroxime by preventing certain bacteria from inactivating the antibiotic. This combination is particularly effective for treating respiratory tract infections, urinary tract infections, skin infections, and other bacterial infections where resistance may be a concern.

Patients may experience some side effects while taking Cefuzrom CV. Commonly reported adverse effects include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. Allergic reactions, though rare, may occur and can manifest as rashes, itching, or swelling. It is crucial for patients to monitor their health and consult a healthcare professional if they experience severe side effects or signs of an allergic reaction.

When taking Cefuzrom CV, it is essential to adhere to the prescribed dosage and complete the full course of treatment, even if symptoms improve before finishing the medication. This practice helps prevent antibiotic resistance and ensures the infection is fully resolved.

Possible side effects include gastrointestinal issues, allergic reactions, and superinfection.

Used for the treatment of bacterial infections such as respiratory, urinary tract, and skin infections.

Consult a healthcare professional before use, especially if you have a history of allergies or kidney problems.

Store in a cool, dry place away from direct sunlight and moisture.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Cefuroxime 500mg + Clavulanic Acid 125mg Tablet in the PCD pharma franchise market?

Cefuroxime 500mg + Clavulanic Acid 125mg Tablet has strong demand in the anti-infective, general medicine, ENT, and respiratory care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced antibiotic portfolios.

Why should medical distributors include Cefuroxime + Clavulanic Acid Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for bacterial infection management under medical supervision. Cefuroxime 500mg is a second-generation cephalosporin antibiotic with broad-spectrum antibacterial activity Clavulanic Acid 125mg is a beta-lactamase inhibitor that helps enhance the effectiveness of cefuroxime against resistant bacterial strains Commonly prescribed for respiratory tract infections, sinusitis, tonsillitis, otitis media, urinary tract infections, skin and soft tissue infections, and other susceptible bacterial infections Provides enhanced antimicrobial coverage and improved treatment outcomes in resistant infections Widely prescribed by general physicians, ENT specialists, and pulmonologists This strengthens a comprehensive anti-infective and respiratory care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Cefuroxime 500mg + Clavulanic Acid 125mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong prescription demand, repeat orders, growing usage in resistant bacterial infections, reliable supply chain support, and attractive margins in the advanced antibiotic segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.